< /P>
(Morning News) The Wall Street Journal of the United States reported on Saturday (February 19) that American Food was reported Products and Drug Administration (FDA) are examiningData, consider whether to authorize the fourth dose of coronary vaccine this fall.
Reuters quoted reports that the review objects include Pfizer and Modner vaccine, and the decisive factor includes whether all adults or specific age group vaccination agents, and whether the enhanced agent should target OmmiKe Rong varters the strain or use a new formula.
It is reported that the examiner is still in the initial stage, and any decision is possible. If a new variant of strains occur, you must vaccinate the enhanced agent in advance.
FDA did not immediately comment on the report.
